Clovis Oncology, Inc. (CLVS): Price and Financial Metrics

CLVS POWR Grades

• Growth is the dimension where CLVS ranks best; there it ranks ahead of 74.53% of US stocks.
• CLVS's strongest trending metric is Growth; it's been moving down over the last 138 days.
• CLVS's current lowest rank is in the Sentiment metric (where it is better than 3.31% of US stocks).

CLVS Stock Summary

• CLVS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.24 -- higher than only 3.15% of US-listed equities with positive expected earnings growth.
• CLVS's price/sales ratio is 0.09; that's higher than the P/S ratio of merely 2.02% of US stocks.
• CLOVIS ONCOLOGY INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -565.06%, greater than the shareholder yield of just 1.2% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to CLOVIS ONCOLOGY INC, a group of peers worth examining would be ALBO, SPRO, OVID, HCWB, and SRDX.
• CLVS's SEC filings can be seen here. And to visit CLOVIS ONCOLOGY INC's official web site, go to www.clovisoncology.com.

CLVS Valuation Summary

• In comparison to the median Healthcare stock, CLVS's EV/EBIT ratio is 143.48% lower, now standing at -3.
• CLVS's price/sales ratio has moved NA NA over the prior 135 months.

Below are key valuation metrics over time for CLVS.

CLVS Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 31.41%.
• Its 5 year price growth rate is now at -86.02%.
• The 4 year price growth rate now stands at -86.02%.

Over the past 33 months, CLVS's revenue has gone down $9,985,000.

The table below shows CLVS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	133.021	-175.575	-251.906
2022-06-30	140.274	-181.034	-263.302
2022-03-31	144.951	-192.662	-258.418
2021-12-31	148.757	-196.057	-264.524
2021-09-30	156.088	-210.767	-299.093
2021-06-30	156.944	-219.022	-310.359

CLVS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CLVS has a Quality Grade of C, ranking ahead of 53.47% of graded US stocks.
• CLVS's asset turnover comes in at 0.279 -- ranking 164th of 682 Pharmaceutical Products stocks.
• NEOG, FLXN, and NSTG are the stocks whose asset turnover ratios are most correlated with CLVS.

The table below shows CLVS's key quality metrics over time.